Literature DB >> 16929503

Fear and avoidance of internal experiences among patients with substance use disorders and PTSD: the centrality of anxiety sensitivity.

Tracy Simpson1, Matthew Jakupcak, Jane A Luterek.   

Abstract

This study evaluated anxiety sensitivity, cognitive avoidance, and alexithymia and their relationship to posttraumatic stress disorder (PTSD) and alcohol use indices concurrently and prospectively in an outpatient substance abuse treatment sample that screened positive for PTSD (N=58). Anxiety sensitivity accounted for substantial variance in the PTSD clusters, reexperiencing, avoidance, and hyperarousal, both concurrently and prospectively. Cognitive avoidance accounted for additional variance with concurrent PTSD avoidance symptoms. Anxiety sensitivity and cognitive avoidance were largely not associated with alcohol use indices. Alexithymia was largely redundant with cognitive avoidance and was, therefore, not included in the regression analyses. Theoretical and treatment implications of these findings are discussed in the context of individuals with dually diagnosed PTSD and substance abuse disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16929503     DOI: 10.1002/jts.20128

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  13 in total

1.  The effect of anxiety sensitivity on alcohol consumption among individuals with comorbid alcohol dependence and posttraumatic stress disorder.

Authors:  Seth J Gillihan; Samantha G Farris; Edna B Foa
Journal:  Psychol Addict Behav       Date:  2011-05-16

2.  Anxiety sensitivity and PTSD symptom severity are reciprocally related: evidence from a longitudinal study of physical trauma survivors.

Authors:  Grant N Marshall; Jeremy N V Miles; Sherry H Stewart
Journal:  J Abnorm Psychol       Date:  2010-02

3.  Anxiety sensitivity and breath-holding duration in relation to PTSD symptom severity among trauma exposed adults.

Authors:  Erin C Berenz; Anka A Vujanovic; Scott F Coffey; Michael J Zvolensky
Journal:  J Anxiety Disord       Date:  2011-10-17

Review 4.  Learning models of PTSD: Theoretical accounts and psychobiological evidence.

Authors:  Shmuel Lissek; Brian van Meurs
Journal:  Int J Psychophysiol       Date:  2014-11-20       Impact factor: 2.997

5.  The role of anxiety sensitivity and difficulties in emotion regulation in posttraumatic stress disorder among crack/cocaine dependent patients in residential substance abuse treatment.

Authors:  Michael J McDermott; Matthew T Tull; Kim L Gratz; Stacey B Daughters; C W Lejuez
Journal:  J Anxiety Disord       Date:  2009-01-20

6.  Mindful awareness in body-oriented therapy for female veterans with post-traumatic stress disorder taking prescription analgesics for chronic pain: a feasibility study.

Authors:  Cynthia J Price; Brittney McBride; Lynne Hyerle; Daniel R Kivlahan
Journal:  Altern Ther Health Med       Date:  2007 Nov-Dec       Impact factor: 1.305

7.  Further Investigation of the Association between Anxiety Sensitivity and Posttraumatic Stress Disorder: Examining the Influence of Emotional Avoidance.

Authors:  Joseph R Bardeen; Matthew T Tull; Erin N Stevens; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2015-07

8.  Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men.

Authors:  Jony Sheynin; Ahmed A Moustafa; Kevin D Beck; Richard J Servatius; Peter A Casbolt; Paul Haber; Mahmoud Elsayed; Lee Hogarth; Catherine E Myers
Journal:  J Clin Psychiatry       Date:  2016-03       Impact factor: 4.384

9.  Anxiety Sensitivity, Emotional Avoidance, and PTSD Symptom Severity Among Crack/Cocaine Dependent Patients in Residential Treatment.

Authors:  James A Naifeh; Matthew T Tull; Kim L Gratz
Journal:  Cognit Ther Res       Date:  2012-06-01

10.  Examining associations between cognitive-affective vulnerability and HIV symptom severity, perceived barriers to treatment adherence, and viral load among HIV-positive adults.

Authors:  Teresa M Leyro; Anka A Vujanovic; Marcel O Bonn-Miller
Journal:  Int J Behav Med       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.